StockWatch
·
Medical Specialities
Quarterly ResultJul 23, 2026, 10:31 AM

Molina Healthcare Q2 Net Income $60M, EPS $1.19; H1 Net Income $74M

AI Summary

Molina Healthcare reported a significant decline in financial performance for Q2 and H1 2026. Net income for the second quarter fell to $60 million ($1.19 diluted EPS) from $255 million ($4.75 diluted EPS) in Q2 2025. For the first six months, net income was $74 million ($1.46 diluted EPS), down from $553 million ($10.19 diluted EPS) in H1 2025. The company also recorded a $93 million impairment charge related to its decision to exit the MAPD product for 2027, shifting focus to dual-eligible members in Medicare.

Key Highlights

  • Q2 2026 Net Income decreased to $60M from $255M in Q2 2025.
  • Q2 2026 Diluted EPS fell to $1.19 from $4.75 in Q2 2025.
  • H1 2026 Net Income was $74M, down from $553M in H1 2025.
  • H1 2026 Diluted EPS was $1.46, compared to $10.19 in H1 2025.
  • Total revenue for Q2 2026 decreased to $10,874M from $11,427M in Q2 2025.
  • Company recorded a $93M impairment charge in H1 2026.
  • Strategic decision to exit MAPD product for 2027 to focus on dual-eligible members.
  • Credit Agreement amended to temporarily reduce Interest Coverage Ratio threshold.